These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 26697959)

  • 1. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
    Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
    Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
    BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
    Basu B; Babu BG; Mahapatra TK
    Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A; Hari P; Moudgil A; Jordan SC
    Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
    Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L
    Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
    Sharma S; Kalra S; Shukla S; Sharma P
    Nephrology (Carlton); 2022 Sep; 27(9):758-762. PubMed ID: 35619554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
    Iijima K; Sako M; Oba M; Tanaka S; Hamada R; Sakai T; Ohwada Y; Ninchoji T; Yamamura T; Machida H; Shima Y; Tanaka R; Kaito H; Araki Y; Morohashi T; Kumagai N; Gotoh Y; Ikezumi Y; Kubota T; Kamei K; Fujita N; Ohtsuka Y; Okamoto T; Yamada T; Tanaka E; Shimizu M; Horinochi T; Konishi A; Omori T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Nozu K;
    J Am Soc Nephrol; 2022 Feb; 33(2):401-419. PubMed ID: 34880074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil for sustained remission in nephrotic syndrome.
    Querfeld U; Weber LT
    Pediatr Nephrol; 2018 Dec; 33(12):2253-2265. PubMed ID: 29750317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Value of Monitoring the Serum Concentration of Mycophenolate Mofetil in Children with Steroid-Dependent/Frequent Relapsing Nephrotic Syndrome.
    Tong K; Mao J; Fu H; Shen H; Liu A; Shu Q; Du L
    Nephron; 2016; 132(4):327-34. PubMed ID: 26991496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
    Yap DY; Yu X; Chen XM; Lu F; Chen N; Li XW; Tang CS; Chan TM
    Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD; MacLeod R; Rigby E; Clark AG
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil in children with frequently relapsing nephrotic syndrome: a report from the Southwest Pediatric Nephrology Study Group.
    Hogg RJ; Fitzgibbons L; Bruick J; Bunke M; Ault B; Baqi N; Trachtman H; Swinford R
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1173-8. PubMed ID: 17699344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
    Geng HY; Ji LN; Chen CY; Tu J; Li HR; Bao R; Lin Y
    Zhonghua Er Ke Za Zhi; 2018 Sep; 56(9):651-656. PubMed ID: 30180402
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome.
    Al-Akash S; Al-Makdama A
    Ann Saudi Med; 2005; 25(5):380-4. PubMed ID: 16270759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
    Barletta GM; Smoyer WE; Bunchman TE; Flynn JT; Kershaw DB
    Pediatr Nephrol; 2003 Aug; 18(8):833-7. PubMed ID: 12774223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
    Okada M; Sugimoto K; Yagi K; Yanagida H; Tabata N; Takemura T
    Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens.
    Wlodarczyk Z; Walaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradszky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Kalmar KN; Hickey D
    Transpl Int; 2005 Feb; 18(2):157-62. PubMed ID: 15691267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.